Science News

... from universities, journals, and other research organizations

On-Site Cardiology Team Dramatically Improves Care for Heart Attack Patients

Apr. 7, 2011 — The availability of an in-house, around-the-clock interventional cardiology team dramatically decreases the time it takes to restore blood flow to heart attack patients, according to data presented this week. These findings were reported by researchers from Loyola University Health System (LUHS) at the American College of Cardiology annual meeting in New Orleans.


Share This:

In April 2009, Loyola became the first hospital in Illinois to launch a Heart Attack Rapid Response Team (HARRT). This group includes an interventional cardiologist, a nurse and other members of the cardiac catheterization team who are available at the hospital 24 hours a day, seven days a week. Most hospitals do not have such teams on site during nights and weekends.

"Valuable time is lost when nurses, doctors and technicians have to be called in from home," said interventional cardiologist John Lopez, MD, study investigator and HARRT co-director, LUHS. "Our staff is on hand and prepared all of the time to meet patients when they arrive and require immediate care."

A task force of the American College of Cardiology and American Heart Association recommends that patients undergoing heart attacks receive balloon angioplasties as soon as possible or within 90 minutes of arriving at the hospital -- known as the "door-to-balloon" time.

These data revealed Loyola has far exceeded this standard since the HARRT program launched, with a median door-to-balloon time of just 47 minutes. All patients received angioplasties within 90 minutes and 82 percent received them within 60 minutes. These results greatly exceed the national standards and results from the best hospitals in the country.

During a heart attack, a blockage in an artery stops blood flow. Heart muscle begins to die due to lack of blood and oxygen. But a balloon angioplasty, if done in time, can stop a heart attack by restoring blood flow.

"Having a team on site 24/7 is the best way to enhance emergency angioplasty times," said Michelle Fennessy, APN, study investigator, LUHS. "By treating patients quickly, you save more lives and improve their prognosis."

Other study investigators from Loyola included Wojciech Nowak DO, PhD, Fred Leya, MD, Robert S. Dieter, MD, Bruce Lewis, MD, Lowell Steen, MD, Mark E. Cichon, DO, Beatrice Probst, MD, Michael Ryan, MD, Jayson Liu, MD, Catherine Smith, RN, MBA, Michael Jarotkiewicz, MBA, David Wilber, MD, and Brian Nguyen, MD.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

|

Story Source:

The above story is reprinted from materials provided by Loyola University Health System, via EurekAlert!, a service of AAAS.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


APA

MLA

Note: If no author is given, the source is cited instead.

Search ScienceDaily

Number of stories in archives: 137,427

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.

Recommend ScienceDaily on Facebook, Twitter, and Google:

Other social bookmarking and sharing services:

|

 
  more breaking science news

Social Networks


Follow ScienceDaily on Facebook, Twitter,
and Google:

Recommend ScienceDaily on Facebook, Twitter, and Google +1:

Other social bookmarking and sharing tools:

|

Breaking News

... from NewsDaily.com

In Other News ...

Science Video News


Test for Imminent Heart Attacks

MPO, or myeloperoxidase,is an enzyme produced by white blood cells. High levels of MPO predict a heart attack, the need for invasive intervention, or. ...  > full story

Strange Science News

 

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

Post this page to your favorite social bookmarking site:
Include this item in your blog or web site:
Cite this article in your essay, paper, or report:
Email this page's link to a friend or colleague: